After treatment with ATRA, known to induce differentiation of embryonal carcinoma NT2 cells [31], LIN28 expression was significantly downregulated, as it happened with pluripotency factors NANOG and POU5F1, with the opposite occurring for PAX6, a marker of differentiation. The gene discussed is LIN28A; the disease is embryonal carcinoma.